Hiroko Okabayashi

746 total citations
30 papers, 176 citations indexed

About

Hiroko Okabayashi is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Oncology. According to data from OpenAlex, Hiroko Okabayashi has authored 30 papers receiving a total of 176 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 7 papers in Epidemiology and 4 papers in Oncology. Recurrent topics in Hiroko Okabayashi's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (22 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Hiroko Okabayashi is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (22 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Hiroko Okabayashi collaborates with scholars based in Japan. Hiroko Okabayashi's co-authors include Hidenori Ichiyasu, Shohei Hamada, Hirotsugu Kohrogi, Shinichiro Okamoto, Kimitaka Akaike, Takashi Ogura, Susumu Hirosako, Hideya Kitamura, T. Oda and Sho Saeki and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Annals of Oncology.

In The Last Decade

Hiroko Okabayashi

27 papers receiving 171 citations

Peers

Countries citing papers authored by Hiroko Okabayashi

Since Specialization

Citations

This map shows the geographic impact of Hiroko Okabayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Okabayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Okabayashi more than expected).

Fields of papers citing papers by Hiroko Okabayashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Okabayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Okabayashi. The network helps show where Hiroko Okabayashi may publish in the future.

Co-authorship network of co-authors of Hiroko Okabayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Okabayashi. A scholar is included among the top collaborators of Hiroko Okabayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Okabayashi. Hiroko Okabayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Case Report: Tattoo sarcoidosis with epithelioid cell granuloma positive for Propionibacterium acnes 2025 ·Frontiers in Medicine ·(unknown), Hiroko Okabayashi, Kimitaka Akaike, Shohei Hamada, (unknown), Hidenori Ichiyasu, Kenichi Ohashi, Takuro Sakagami	1
2	The impact of factor Xa inhibitors on bleeding risk in patients with respiratory diseases 2024 ·Scientific Reports ·Shohei Hamada, (unknown), Kimitaka Akaike, Hiroko Okabayashi, (unknown), Yusuke Tomita, Hidenori Ichiyasu, Takuro Sakagami	1
3	Tension Pneumomediastinum in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease: A Case Report and Literature Review 2024 ·Internal Medicine ·Hiroko Okabayashi, (unknown), Kosuke Fujino, (unknown), Shohei Hamada, (unknown), Hidenori Ichiyasu, Makoto Suzuki, Takuro Sakagami	1
4	Comparison of nintedanib-induced gastrointestinal adverse events between patients with systemic sclerosis-associated interstitial lung disease and idiopathic interstitial pneumonias 2024 ·Respiratory Investigation ·(unknown), Hiroko Okabayashi, Kimitaka Akaike, Shohei Hamada, (unknown), Hidenori Ichiyasu, Takuro Sakagami	2
5	Clinical impact of SUVmax of interstitial lesions in lung cancer patients with interstitial lung disease who underwent pulmonary resection 2022 ·Journal of Thoracic Disease ·Kimitaka Akaike, Koichi Saruwatari, (unknown), Kosuke Fujino, Jun Morinaga, Seitaro Oda, Hiroshi Takahashi, Shinya Shiraishi, Hiroko Okabayashi, Shohei Hamada, Yusuke Tomita, (unknown), Sho Saeki, Koei Ikeda, Hidenori Ichiyasu, Makoto Suzuki, Takuro Sakagami	2
6	The new useful high-resolution computed tomography finding for diagnosing fibrotic hypersensitivity pneumonitis: “hexagonal pattern”: a single-center retrospective study 2022 ·BMC Pulmonary Medicine ·Hiroko Okabayashi, (unknown), Tae Iwasawa, T. Oda, Hideya Kitamura, Tomohisa Baba, Tamiko Takemura, Takuro Sakagami, Takashi Ogura	6
7	Predictive factors for the long-term use of pirfenidone in patients with fibrosing interstitial lung disease 2021 ·Respiratory Investigation ·(unknown), Akimasa Sekine, Satoshi Ikeda, Hideaki Yamakawa, Toshihiro Misumi, Hiroko Okabayashi, Ryo Okuda, Hideya Kitamura, Tomohisa Baba, Shigeru Komatsu, Eri Hagiwara, Takashi Ogura	2
8	Impact of interstitial pneumonia complications on palliative medication for terminal lung cancer: A single-center retrospective study 2021 ·Respiratory Investigation ·Hiroko Okabayashi, Hideya Kitamura, Satoshi Ikeda, Akimasa Sekine, T. Oda, Tomohisa Baba, Eri Hagiwara, Takuro Sakagami, Takashi Ogura	1
9	Patients with Terminal Interstitial Pneumonia Require Comparable or More Palliative Pharmacotherapy for Refractory Dyspnea than Patients with Terminal Lung Cancer 2021 ·SHILAP Revista de lepidopterología ·Hiroko Okabayashi, Hideya Kitamura, Satoshi Ikeda, Akimasa Sekine, T. Oda, Tomohisa Baba, Eri Hagiwara, Takuro Sakagami, Takashi Ogura	2
10	Serum Krebs von den Lungen-6 levels are associated with mortality and severity in patients with coronavirus disease 2019 2021 ·Respiratory Investigation ·(unknown), Eri Hagiwara, Tomohisa Baba, (unknown), Kota Murohashi, (unknown), Yozo Sato, (unknown), (unknown), (unknown), Hiroko Okabayashi, Satoshi Ikeda, Takashi Niwa, (unknown), T. Oda, Ryo Okuda, Akimasa Sekine, Hideya Kitamura, Shigeru Komatsu, Takashi Ogura	17
11	Asbestos exposure and tuberculous pleurisy as developmental causes of progressive unilateral upper-lung field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosis 2021 ·Respiratory Investigation ·Akimasa Sekine, Eri Hagiwara, Tae Iwasawa, (unknown), (unknown), (unknown), Hiroko Okabayashi, Satoshi Ikeda, T. Oda, Ryo Okuda, Hideya Kitamura, Tomohisa Baba, Shigeru Komatsu, Takashi Ogura	3
12	A case of exogenous lipoid pneumonia diagnosed by transbronchial lung cryobiopsy 2021 ·Respiratory Investigation ·(unknown), Shigeru Komatsu, (unknown), Hiroko Okabayashi, Takashi Niwa, Ryo Okuda, Tomohisa Baba, Eri Hagiwara, Takashi Ogura	0
13	Unilateral upper lung-field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosis after thoracic surgery: Clinical and radiological courses with autopsy findings 2020 ·Respiratory Investigation ·Akimasa Sekine, Hiroaki Satoh, Tamiko Takemura, Mai Matsumura, Koji Okudela, Tae Iwasawa, Hiroko Okabayashi, Satoshi Ikeda, Hideaki Yamakawa, T. Oda, Ryo Okuda, Hideya Kitamura, Tomohisa Baba, Shigeru Komatsu, Eri Hagiwara, Takashi Ogura	7
14	Evaluation of lymphocytic infiltration in the bronchial glands of Sjögren’s syndrome in transbronchial lung cryobiopsy 2020 ·BMC Pulmonary Medicine ·Hiroko Okabayashi, Tomohisa Baba, (unknown), (unknown), (unknown), Satoshi Ikeda, Takashi Niwa, T. Oda, Ryo Okuda, Akimasa Sekine, Hideya Kitamura, Shigeru Komatsu, Eri Hagiwara, Tamiko Takemura, Takuro Sakagami, Takashi Ogura	1
15	Acute Exacerbation of Idiopathic Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma after Transcatheter Arterial Therapy Using Miriplatin 2019 ·Internal Medicine ·(unknown), Shinya Sakata, Kazuyoshi Nakamura, Hiroko Okabayashi, Kimitaka Akaike, Takayuki Tokunaga, Sho Saeki, Kazuhiko Fujii, Hidenori Ichiyasu	0
16	Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer 2019 ·BMC Pulmonary Medicine ·Shohei Hamada, Hidenori Ichiyasu, Tokunori Ikeda, (unknown), Kosuke Kashiwabara, (unknown), Nahoko Sato, Kimitaka Akaike, Hiroko Okabayashi, Koichi Saruwatari, Yusuke Tomita, Sho Saeki, Naomi Hirata, Takeshi Yoshinaga, Kazuhiko Fujii	30
17	The impact of continuing ALK inhibitors beyond initial disease progression on clinical outcome in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter retrospective analysis 2018 ·Annals of Oncology ·Shinya Sakata, Sho Saeki, Yoshihiko Sakata, Kodai Kawamura, Kazuya Ichikado, (unknown), Sunao Ushijima, (unknown), Kazuhiro Iyonaga, Toshihiro Kumabe, Rikiya Fujita, Kosuke Kashiwabara, Shinji Fujii, Teruya Komatsu, Osamu Sakamoto, Hiroko Okabayashi, Koichi Saruwatari, Yusuke Tomita, Takuro Sakagami	1
18	Negative Impact of Coexisting Interstitial Lung Disease on Clinical Outcomes in Small-cell Lung Cancer Patients 2018 ·Anticancer Research ·Kimitaka Akaike, Koichi Saruwatari, Hiroko Okabayashi, Shohei Hamada, (unknown), Takayuki Jodai, Shinya Sakata, Shinji Iyama, Ryo Sato, (unknown), Yusuke Tomita, Sho Saeki, Hidenori Ichiyasu, Kazuhiko Fujii	3
19	Rapidly progressive interstitial lung disease due to anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis complicated with cervical cancer: Successful treatment with direct hemoperfusion using polymyxin B-immobilized fiber column therapy 2016 ·Respiratory Medicine Case Reports ·Hidenori Ichiyasu, (unknown), (unknown), Kazuhiko Sakamoto, (unknown), (unknown), Hiroko Okabayashi, Sho Saeki, Shinichiro Okamoto, Hirotsugu Kohrogi	21
20	Detection of ALK rearrangement in an octogenarian patient with pleomorphic carcinoma of the lung 2014 ·General Thoracic and Cardiovascular Surgery ·Riichiroh Maruyama, Fujio Matsumura, Yuji Shibata, Hiroshi Takahashi, Hiroko Okabayashi, (unknown), Izumi Honda, Susumu Ohkawara, Mineharu Sugimoto	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact